The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells

By sjmartinez • December 14, 2023

Lewis MI, Shapiro S, Oudiz RJ, Nakamura M, Geft D, Matusov Y, Hage A, Tapson VF, Henry TD, Azizad P, Saggar R, Mirocha J, Karpov OA, Van Eyk JE, Marbán E. The ALPHA phase 1 study: pulmonary ArteriaL hypertension treated with CardiosPHere-Derived allogeneic stem cells. EBioMedicine. 2023 Dec 7:104900. doi: 10.1016/j.ebiom.2023.104900. Epub ahead of print. PMID: 38092579.

Tags: Cardiology/Epi, Harbor UCLA, Progenitor cell therapy, Publications, pulmonary arterial hypertension, Regenerative medicine, right ventricle, Short- and long-term safety

Photosensitizer proximity labeling captures the lipid and protein interactomes

Becker AP, Biletch E, Kennelly JP, Hong SG, Julio AR, Villanueva M, Nagari RT, Turner DW, Burton NR, Fukuta T, Cui L, Xiao X, Vellani[...]

Reperfusion Strategies for Acute Pulmonary Embolism: Design and Rationale of RECONNECT-PE – a Living Systematic Review and Meta-analysis

Farmakis IT, Binder H, Chopard R, Christodoulou KC, Evrenoglou T, Fengler K, Giri J, Hobohm L, Jaber WA, Klok FA, Kocka V, Kroupa J, Kucher[...]

MoCo + ROVir: Synergy Between Respiratory Motion Compensation and Cardiac Receive Region Focusing for Cardiac MRI

Hu Z, Lee HL, Cao T, Yoshida T, Ma L, Finn JP, Nguyen KL, Christodoulou AG. MoCo + ROVir: Synergy Between Respiratory Motion Compensation and Cardiac Receive[...]